BR112015013945A2 - grânulos de ibuprofeno com alto teor de sódio, sua preparação e seu uso na preparação de formas de dosagem sólidas não efervescentes - Google Patents

grânulos de ibuprofeno com alto teor de sódio, sua preparação e seu uso na preparação de formas de dosagem sólidas não efervescentes

Info

Publication number
BR112015013945A2
BR112015013945A2 BR112015013945A BR112015013945A BR112015013945A2 BR 112015013945 A2 BR112015013945 A2 BR 112015013945A2 BR 112015013945 A BR112015013945 A BR 112015013945A BR 112015013945 A BR112015013945 A BR 112015013945A BR 112015013945 A2 BR112015013945 A2 BR 112015013945A2
Authority
BR
Brazil
Prior art keywords
preparation
dosage forms
solid dosage
high sodium
sodium ibuprofen
Prior art date
Application number
BR112015013945A
Other languages
English (en)
Other versions
BR112015013945A8 (pt
Inventor
W Liimatta Eric
H Lambeth Gregory
N Boudoin Latria
C Hu Patrick
Original Assignee
Si Group Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=49841833&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR112015013945(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US13/714,768 external-priority patent/US9629809B2/en
Application filed by Si Group Inc filed Critical Si Group Inc
Publication of BR112015013945A2 publication Critical patent/BR112015013945A2/pt
Publication of BR112015013945A8 publication Critical patent/BR112015013945A8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
BR112015013945A 2012-12-14 2013-12-04 grânulos de alto teor de ibuprofeno de sódio, preparação do mesmo e uso do mesmo na preparação de formas de dosagem sólidas não-efervescentes BR112015013945A8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13/714,768 US9629809B2 (en) 2008-07-21 2012-12-14 High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms
PCT/US2013/072981 WO2014093073A1 (en) 2012-12-14 2013-12-04 High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms

Publications (2)

Publication Number Publication Date
BR112015013945A2 true BR112015013945A2 (pt) 2017-07-11
BR112015013945A8 BR112015013945A8 (pt) 2019-10-08

Family

ID=49841833

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112015013945A BR112015013945A8 (pt) 2012-12-14 2013-12-04 grânulos de alto teor de ibuprofeno de sódio, preparação do mesmo e uso do mesmo na preparação de formas de dosagem sólidas não-efervescentes

Country Status (9)

Country Link
EP (1) EP2931261A1 (pt)
JP (1) JP6285952B2 (pt)
CN (1) CN104884048B (pt)
BR (1) BR112015013945A8 (pt)
CA (1) CA2894272A1 (pt)
CL (1) CL2015001621A1 (pt)
HK (1) HK1210591A1 (pt)
MX (1) MX2015007571A (pt)
WO (1) WO2014093073A1 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019043614A1 (en) 2017-08-31 2019-03-07 Novartis Ag PROCESS FOR THE PREPARATION OF GRANULES

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1293764B1 (it) * 1997-07-23 1999-03-10 Chiesi Farma Spa Composizioni farmaceutiche sotto forma di compresse effervescenti contenenti un principio attivo instabile in presenza di acqua
JP4753567B2 (ja) * 2004-11-19 2011-08-24 旭化成ケミカルズ株式会社 付着性の高い薬物を含有する錠剤の製造方法
DE102005009241A1 (de) * 2005-03-01 2006-09-07 Bayer Healthcare Ag Arzneiformen mit kontrollierter Bioverfügbarkeit
JP5553830B2 (ja) * 2008-07-21 2014-07-16 アルベマール・コーポレーシヨン 高含量イブプロフェンナトリウム顆粒、その調製、および非発泡性固体剤形を調製する際のその使用
MX2020011961A (es) * 2010-03-24 2022-04-19 Jazz Pharmaceuticals Inc Formas de dosis de liberacion controlada para substancias de farmaco de alta dosis, solubles en agua e higroscopicas.

Also Published As

Publication number Publication date
JP2016508124A (ja) 2016-03-17
BR112015013945A8 (pt) 2019-10-08
CN104884048B (zh) 2018-11-23
WO2014093073A1 (en) 2014-06-19
CA2894272A1 (en) 2014-06-19
MX2015007571A (es) 2016-04-15
CN104884048A (zh) 2015-09-02
JP6285952B2 (ja) 2018-02-28
HK1210591A1 (en) 2016-04-29
EP2931261A1 (en) 2015-10-21
CL2015001621A1 (es) 2015-08-07

Similar Documents

Publication Publication Date Title
BR112016000825A2 (pt) compostos moduladores de sulfonamidas dos canais de sódio, composição farmacêutica, e uso dos mesmos
CR20150380A (es) Compuestos de carbamoilpiridona policíclicos y su uso farmacéutico
BR112015020118A2 (pt) derivados de 2-aminopirimidina para o tratamento de infecções virais
BR112015011036A2 (pt) derivados de 2-amino-quinazolina substituídos heterocíclicos para o tratamento de infecções virais
BR112016003480A2 (pt) ensaios para detecção de molécula única e seu uso
BR112015015891A8 (pt) Composição farmacêutica de solução sólida, e, uso de uma composição farmacêutica
IT1403661B1 (it) Composizione effervescente in forma solida per uso in applicazioni vaginali per il trattamento di infezioni vaginali.
BR112015000420A2 (pt) composto, composição farmacêutica, e, uso de um composto
BR112016013714A2 (pt) compostos cristalinos de análogos de sofosbuvir antivirais, uso dos mesmos e composição farmacêutica
BR112014000049A2 (pt) pirrolotriazinas substituídas com hidroximelilarilo e sua utilização
BR112013022556A8 (pt) composição farmacêutica aquosa semissólida contendo tapentadol, seu uso e uso de tapentadol
BR112013015378A2 (pt) misturador dinâmico e seu uso
BR112014010458A2 (pt) n-(pirid-4-il)amidas e n-(pirimidin-4-il)amidas e seu uso farmacêutico e cosmético
DK3556350T3 (da) Farmaceutisk præparat indeholdende et antiviralt aktivt dihydroquinazolinderivat med s-konfiguration i 4-stillingen
BR112013022883A2 (pt) aptâmero, composição farmacêutica, kit, uso de um aptâmero e coluna de aférese
BR112013022285A2 (pt) proteína de fusão de fgfr-fc e o seu uso
BR112015027026A2 (pt) composição para uso na redução da formação de crosta e na promoção da cicatrização
BR112012024996A2 (pt) uso de pelo menos um tiossulfinato ou tiossulfinato de tiossulfinato de dialquila para reduzir o número de apicompelox em um animal
BR112014025416A2 (pt) AGENTES ANTIMALÁRICOS, COMPOSIÇÃO FARMACEUTICA COMPREENDENDO-OS E USO Dos MESMOS.
CL2015001730A1 (es) Compuestos triciclos inhibidores del canal cftr; composicion y combinacion farmaceutica; y uso en el tratamiento de la enfermedad renal poliquistica y diarrea.
EP2985029A4 (en) MEDICATION FOR EXTERNAL USE IN CLEANING AND CARE OF OVARIES, VAGS AND VULVES
BR112013004659A2 (pt) teobromina em combinação com um expectorante ou um mucolítico para uso em terapia
BR112014016471A8 (pt) uso de uma solução aquosa e chapa
CL2014003484A1 (es) Uso de nalmefeno en la reduccion del consumo de alcohol en un paciente con dependencia del alcohol; composicion farmaceutica oral; combinacion farmaceutica.
SMT201700004B (it) Uso di estratti di salvia haenkei in composizioni per antisenescenza

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law
B06F Objections, documents and/or translations needed after an examination request according art. 34 industrial property law
B06F Objections, documents and/or translations needed after an examination request according art. 34 industrial property law
B06I Technical and formal requirements: publication cancelled

Free format text: ANULADA A PUBLICACAO CODIGO 6.6.1 NA RPI NO 2462 DE 13/03/2018 POR TER SIDO INDEVIDA.

B07E Notice of approval relating to section 229 industrial property law

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06U Preliminary requirement: requests with searches performed by other patent offices: suspension of the patent application procedure
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements